Guardian Capital (Canada)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Guardian Capital (Canada)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-141,496	Closed	-$5.13M	–	224
2016 Q4	$5.13M	Sell	141,496 -9,142	-6%	-$365K	0.08%	111
2016 Q3	$6.93M	Sell	150,638 -72,304	-32%	-$3.77M	0.11%	99
2016 Q2	$11.2M	Sell	222,942 -2,191	-1%	-$117K	0.18%	73
2016 Q1	$12M	Sell	225,133 -23,468	-9%	-$1.38M	0.2%	69
2015 Q4	$16.3M	Buy	248,601 +33,910	+16%	+$2.1M	0.31%	57
2015 Q3	$12.1M	Buy	214,691 +23,491	+12%	+$1.52M	0.23%	62
2015 Q2	$11.3M	Buy	191,200 +25,140	+15%	+$1.55M	0.19%	68
2015 Q1	$10.3M	Buy	166,060 +18,805	+13%	+$1.09M	0.18%	65
2014 Q4	$8.47M	Buy	+147,255	New	+$8.2M	0.14%	71

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Guardian Capital (Canada)'s TEVA Position: Q1 2017 in Review

Guardian Capital (Canada) sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2017, closing a stake of 141,496 shares — an estimated $5.13M sold.

Guardian Capital (Canada) first reported a position in TEVA in Q4 2014 and held it in 9 quarters. The position peaked at $16.3M in Q4 2015. 688 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

Guardian Capital (Canada) reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2017 after selling out during the quarter.
Guardian Capital (Canada) sold 141,496 Teva Pharmaceutical Industries Limited shares in Q1 2017, an estimated $5.13M.
Guardian Capital (Canada) first reported a position in Teva Pharmaceutical Industries Limited in Q4 2014 and held it in 9 quarters.
Guardian Capital (Canada)'s Teva Pharmaceutical Industries Limited position peaked at $16.3M in Q4 2015.
688 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2017.

Based on Guardian Capital (Canada)'s 13F filing for Q1 2017, filed 15 May 2017.